Product NDC: | 0078-0110 |
Proprietary Name: | Sandimmune |
Non Proprietary Name: | cyclosporine |
Active Ingredient(s): | 100 mg/mL & nbsp; cyclosporine |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0078-0110 |
Labeler Name: | Novartis Pharmaceuticals Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050574 |
Marketing Category: | NDA |
Start Marketing Date: | 19831114 |
Package NDC: | 0078-0110-22 |
Package Description: | 50 mL in 1 BOTTLE (0078-0110-22) |
NDC Code | 0078-0110-22 |
Proprietary Name | Sandimmune |
Package Description | 50 mL in 1 BOTTLE (0078-0110-22) |
Product NDC | 0078-0110 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cyclosporine |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19831114 |
Marketing Category Name | NDA |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | CYCLOSPORINE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |